Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau.
about
One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100.Interferon-Tau has Antiproliferative effects, Represses the Expression of E6 and E7 Oncogenes, Induces Apoptosis in Cell Lines Transformed with HPV16 and Inhibits Tumor Growth In Vivo.
P2860
Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Characterization of anti-tumor ...... he fusion protein RM4/IFN-tau.
@en
type
label
Characterization of anti-tumor ...... he fusion protein RM4/IFN-tau.
@en
prefLabel
Characterization of anti-tumor ...... he fusion protein RM4/IFN-tau.
@en
P2093
P1476
Characterization of anti-tumor ...... he fusion protein RM4/IFN-tau.
@en
P2093
P577
1996-01-01T00:00:00Z